- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Chronic Obstructive Pulmonary Disease, COPD in Mexico
Total 1019 results
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease, COPDFrance, Poland, South Africa, Spain, United States, Canada, United Kingdom
-
National Institute of Respiratory Diseases, MexicoUnknownChronic Obstructive Pulmonary DiseaseMexico
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Colombia, Argentina, Germany, Spain, Turkey, Guatemala, Mexico, Australia, Denmark, South Africa, Philippines
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Germany, Argentina, Bulgaria, Poland, Turkey, Mexico, United Kingdom
-
National Institute of Respiratory Diseases, MexicoCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Colombia, India, Korea, Republic of, Poland, Croatia, Estonia, Hungary, United Kingdom, Israel, Latvia, Turkey, Argentina, Panama, Mexico, Russian Federation, Serbia, Slovenia
-
SunovionCompleted
-
Pearl Therapeutics, Inc.Completed
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Czechia, Denmark, Hungary, Netherlands, Spain, Korea, Republic of, Argentina, Belgium, Bulgaria, Finland, India, Japan, Mexico, Norway, Sweden, Turkey, Vietnam, Portugal, Puerto Rico
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary Disease | COPDUnited States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Argentina, Australia, Canada, Mexico, New Zealand, South Africa
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Colombia, India, Korea, Republic of, Poland, Romania, South Africa, Italy, Austria, Belgium, Croatia, Estonia, Hungary, Russian Federation, Taiwan, Turkey, Japan, Spain, Sweden, United Kingdom, China, Thailand, Canada, Hong Kong and more
-
AstraZenecaRecruitingCOPD (Chronic Obstructive Pulmonary Disease)United States, Korea, Republic of, Argentina, Turkey, Vietnam, Malaysia, Philippines, Thailand, Hungary, Mexico, Canada, India, Bulgaria, Poland
-
AstraZenecaAmgenCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Denmark, France, United Kingdom, Korea, Republic of, Germany, Israel, Spain, Netherlands
-
AstraZenecaActive, not recruitingChronic Obstructive Pulmonary Disease (COPD)United States, Denmark, Italy, United Kingdom, Canada, Germany, Turkey, Argentina, South Africa, Spain, Poland, Bulgaria, Mexico, Netherlands
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States, Australia, New Zealand
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)China, United States, Denmark, Italy, Germany, Hungary, Netherlands, Spain, United Kingdom, Belgium, Argentina, Bulgaria, Canada, India, Japan, Vietnam, Brazil, Malaysia, Thailand, France, Mexico, Greece, Poland, Korea, Republic of, Peru, Chil... and more
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)China, Denmark, United States, Australia, Germany, Netherlands, Poland, Spain, United Kingdom, Korea, Republic of, Philippines, Italy, Argentina, Belgium, Bulgaria, Canada, Czechia, Finland, Hungary, India, Japan, Mexico, Norway, Port... and more
-
AstraZenecaRecruitingCOPD (Chronic Obstructive Pulmonary Disease)France, Denmark, Italy, Spain, United States, Canada, Argentina, Japan, Colombia, Germany, Peru, Brazil, China, India, Thailand, Austria, Serbia, Malaysia, Philippines, Poland, Taiwan, Greece, Norway, Sweden, Mexico, Romania, Korea, Republic... and more
-
Hoffmann-La RocheRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, China, Spain, Italy, Germany, Belgium, Korea, Republic of, Poland, Taiwan, Israel, New Zealand, Sweden, United Kingdom, Japan, Czechia, Philippines, Hong Kong, Greece, Australia, Thailand, Netherlands, Argentina, Brazil, Fran... and more
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Germany, Spain, Turkey, Hungary, Czech Republic, India, Slovakia
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPDUnited States, Argentina, Canada, Colombia, Mexico, Peru
-
AstraZenecaCompletedLung Diseases | Pulmonary Disease | COPD | COPD Exacerbation | Respiratory Disorders | Chronic Obstructive Airway Disease | Chronic Obstructive Lung DiseasesUnited States, Argentina, Canada, Chile, Colombia, Italy, Malaysia, Mexico, Peru, Philippines, Romania, Russian Federation, Serbia, Spain, Taiwan, Thailand, Ukraine
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseTaiwan, Russian Federation, Mexico, Chile
-
AstraZenecaParexelCompletedChronic Obstructive Pulmonary Disease | Asthma | COPDUnited States, Canada, Germany, Italy, Spain, United Kingdom, Mexico, Australia, Argentina, France, China, Japan, Brazil, Korea, Republic of, Colombia, Denmark, Netherlands, Norway, Sweden
-
Instituto Nacional de Enfermedades RespiratoriasRecruitingHeart Failure | Copd | Pulmonary Rehabilitation | Nutritional SupplementationMexico
-
Chiesi Farmaceutici S.p.A.RecruitingCOPD | COPD ExacerbationUnited States, Bulgaria, Hungary, Poland, Argentina, Czechia, Mexico, Canada, Puerto Rico, Romania
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseColombia, Italy, Switzerland, Argentina, United Kingdom, Mexico, Netherlands, Malaysia, Spain
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseArgentina, Dominican Republic, Panama, Mexico, Brazil, Chile, Ecuador, Honduras
-
US Department of Veterans AffairsTerminatedEmphysema | COPDUnited States
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
DeyCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Hoffmann-La RocheCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada, Bulgaria, Hungary, Russian Federation, Denmark, Argentina, Mexico, Poland
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States, Spain, Switzerland, France, Italy, Germany, Turkey, Hungary, Norway, Slovakia, Poland, Russian Federation, Canada, Belgium, Austria, Colombia, Denmark, Finland, Greece, Israel, Mexico, United Kingdom
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Denmark, France, Sweden, Thailand, Vietnam, Belgium, Brazil, Peru, Philippines, Turkey, Taiwan, Argentina, Australia, Israel, Poland, Ukraine, Slovenia, Serbia, Mexico, Bulgaria, Colombia, New Zealand, Chile, Norway, Croatia
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Germany, Italy, Netherlands, Spain, United Kingdom, Poland, Japan, Austria, Korea, Republic of, Russian Federation, South Africa, Czechia, Hungary, Romania, Switzerland
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, Argentina, Japan, Russian Federation, Spain, Germany, Mexico, Romania, Korea, Republic of, Poland, Italy, France
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, New Zealand
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Bulgaria, Germany, Hungary, Romania, Denmark, Greece, Mexico, Iceland
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseUnited States, Argentina, Germany, Russian Federation, France, Israel, Korea, Republic of, Italy, Poland, Chile, Mexico, Peru, Canada, Hungary, Netherlands, New Zealand
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Poland, Romania, Russian Federation, Ukraine, Bulgaria, Estonia, Mexico, Korea, Republic of, Slovakia, Greece, China, Italy, Hungary, Czechia
-
SanofiRegeneron PharmaceuticalsRecruitingChronic Obstructive Pulmonary DiseaseBulgaria, China, United States, Argentina, Chile, Czechia, Georgia, Greece, Hungary, India, Israel, Italy, Mexico, Poland, Romania, Russian Federation, Slovakia, Taiwan, Ukraine, United Kingdom, Mauritius
-
Chiesi Farmaceutici S.p.A.RecruitingChronic Obstructive Pulmonary DiseaseBulgaria, United States, Albania, Argentina, Australia, Austria, Bosnia and Herzegovina, Chile, China, Czechia, Georgia, Germany, Greece, Hungary, Israel, Italy, Mexico, Netherlands, New Zealand, North Macedonia, Poland, Romania, Russian... and more
-
Hoffmann-La RocheRecruitingChronic Obstructive Pulmonary DiseaseUnited States, Belgium, Australia, Israel, Spain, France, United Kingdom, Denmark, Argentina, Germany, New Zealand, South Africa, Korea, Republic of, Poland, Bulgaria, Canada, Chile, Czechia, Netherlands, Romania, Sweden, Mexico
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseGermany, United States, Colombia, Poland, South Africa, Canada, Estonia, Hungary, India, Austria, Israel, Netherlands, United Kingdom, Argentina, France, Italy, Spain, Czech Republic, Denmark, Finland, Greece, Ireland, Mexico, Peru, Phi... and more
-
Genentech, Inc.Active, not recruitingChronic Obstructive Pulmonary DiseaseUnited States, Israel, Australia, Denmark, Korea, Republic of, Spain, Belgium, France, Bulgaria, Poland, United Kingdom, Germany, Canada, Netherlands, Peru, Argentina, Hong Kong, South Africa, New Zealand, Sweden, Czechia, Chile, Ro... and more
-
SanofiRegeneron PharmaceuticalsRecruitingChronic Obstructive Pulmonary DiseaseKorea, Republic of, Turkey, United States, Chile, Czechia, Israel, Russian Federation, Argentina, Brazil, Bulgaria, Canada, Denmark, Estonia, France, Georgia, Germany, Hungary, India, Japan, Latvia, Lithuania, Mexico, Netherlands, Norway and more
-
SanofiRegeneron PharmaceuticalsActive, not recruitingChronic Obstructive Pulmonary DiseaseGreece, Belgium, Spain, Argentina, Hungary, South Africa, United Kingdom, France, Latvia, Germany, Netherlands, Russian Federation, Ukraine, United States, Australia, Brazil, Bulgaria, Canada, Chile, Colombia, Czechia, Lithuania, Me... and more